Log In
Tuesday 22nd May 2018

Osteoporosis patients to get limited drug choice

9th December 2009

The National Institute for Health and Clinical Excellence has announced that osteoporosis patients will only be given the least costly treatment until their condition deteriorates.

The guidance has been criticised by consultant rheumatologist Professor Tim Spector from St Thomas' Hospital,  who told the Daily Mail: "Many of my patients are unable to tolerate the treatment recommended by NICE and will have to wait for their disease to deteriorate before I can give them an alternative treatment. This would leave them unprotected from the risk of fracture for [a] possible three years."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018